Variant report
Variant | nsv964914 |
---|---|
Chromosome Location | chr5:99349660-99352102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191784014 | chr5:99351046-99351047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76446326 | chr5:99351094-99351095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116196555 | chr5:99351101-99351102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554970610 | chr5:99351131-99351132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs151266459 | chr5:99351135-99351136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184073218 | chr5:99351145-99351146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543338096 | chr5:99351146-99351147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370644811 | chr5:99351173-99351174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187894262 | chr5:99351234-99351235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558823570 | chr5:99351247-99351248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192370436 | chr5:99351270-99351271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544430735 | chr5:99351314-99351315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184113608 | chr5:99351324-99351325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574806899 | chr5:99351335-99351336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368522654 | chr5:99351342-99351343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187285991 | chr5:99351347-99351348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140491025 | chr5:99351503-99351504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552149692 | chr5:99351506-99351507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533161943 | chr5:99351513-99351514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531419043 | chr5:99351550-99351551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11948786 | chr5:99351584-99351585 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs75565633 | chr5:99351595-99351596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73774516 | chr5:99351625-99351626 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs72769531 | chr5:99351666-99351667 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs565953610 | chr5:99351721-99351722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533984285 | chr5:99351753-99351754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542392547 | chr5:99351759-99351760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9654525 | chr5:99351839-99351840 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs114062639 | chr5:99351856-99351857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78304763 | chr5:99351968-99351969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556358827 | chr5:99352054-99352055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574643875 | chr5:99352078-99352079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99351000-99353200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr5:99351200-99351400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr5:99351400-99353200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr5:99351600-99352600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |